Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Other Non Operating Income: 2013-2024

Historic Other Non Operating Income for vTv Therapeutics (VTVT) over the last 10 years, with Dec 2024 value amounting to $160,000.

  • vTv Therapeutics' Other Non Operating Income fell 140.00% to -$34,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $325,000, marking a year-over-year increase of 319.59%. This contributed to the annual value of $160,000 for FY2024, which is 110.69% up from last year.
  • vTv Therapeutics' Other Non Operating Income amounted to $160,000 in FY2024, which was up 110.69% from -$1.5 million recorded in FY2023.
  • vTv Therapeutics' Other Non Operating Income's 5-year high stood at $2.4 million during FY2021, with a 5-year trough of -$3.6 million in FY2022.
  • Moreover, its 3-year median value for Other Non Operating Income was -$1.5 million (2023), whereas its average is -$1.7 million.
  • As far as peak fluctuations go, vTv Therapeutics' Other Non Operating Income crashed by 247.71% in 2022, and later spiked by 110.69% in 2024.
  • vTv Therapeutics' Other Non Operating Income (Yearly) stood at $2.4 million in 2021, then tumbled by 247.71% to -$3.6 million in 2022, then skyrocketed by 58.60% to -$1.5 million in 2023, then soared by 110.69% to $160,000 in 2024.